Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U6 small nuclear 1276, pseudogene (RNU6-1276P)
- Target
- RNU6-1276P
- Molecular classification
- Other (specifically, pseudogene of small nuclear RNA), Small nuclear RNA-derived pseudogene
01
Overview
RNU6-1276P is a human pseudogene of the U6 small nuclear RNA (snRNA) family. U6 snRNA itself plays a crucial role in mRNA splicing as part of the spliceosome complex in eukaryotes. However, RNU6-1276P is a pseudogene, meaning it does not produce a functional U6 snRNA and does not contribute to canonical splicing or other active processes. Pseudogenes such as this one often result from the duplication or retrotransposition of functional RNA genes, and while many are transcriptionally inactive, some may act as competing endogenous RNAs or regulate parental gene expression under certain circumstances. For RNU6-1276P specifically, there are no known regulatory or pathological roles currently described in the scientific literature.
- Other names
- RNA, U6 small nuclear 1276, pseudogeneRNU6-1276PGC08P027639 (previous GeneCards identifier)GC00U936054 (previous GeneCards identifier)HGNC: 48239NCBI Gene: 106481583Ensembl: ENSG00000202242
02
Mechanism of action
None. Since RNU6-1276P does not encode a protein and shows no pharmacological interactions, there are no mechanisms of action for drugs
03
Biological functions
Typically, pseudogenes do not encode an active product. However, some pseudogenes can regulate gene expression post-transcriptionally or epigenetically, although direct evidence for RNU6-1276P involvement is lacking
04
Disease associations
Other. There is no evidence that RNU6-1276P itself is implicated directly in disease. Generally, pseudogenes can regulate gene expression via miRNA sponging or lncRNA generation, but there are no known disease associations specifically described for RNU6-1276P
05
Safety considerations
None. As a non-coding pseudogene with no functional product or known regulatory significance, there are no safety concerns or therapeutic challenges identified
06
Interacting drugs
None
07
Biomarkers
None
Beyond the preview
Go deeper on RNA, U6 small nuclear 1276, pseudogene (RNU6-1276P).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on RNA, U6 small nuclear 1276, pseudogene (RNU6-1276P).